Showing results (1811-1820 of 1,899) with videos related to

Sort By:
Pageof 190
Immunotherapy|September 11, 2024
Occult checkpoint inhibitor myocarditis during adjuvant nivolumab plus ipilimumab: a smoldering but severe toxicityDimitrios Bafaloukos, Ioanna Gazouli, Aikaterini Bousmpoukea, et al.
Immunotherapy|August 19, 2024
Peripheral blood cytokines and outcomes with immune checkpoint blockade: a systematic review and meta-analysisAlexander B Karol, Yu Fujiwara, Tyler D'Ovidio, et al.
Immunotherapy|November 26, 2024
Identifying risk factors and biomarkers for severe CIP in lung cancer patients- a retrospective case series studyGuixian Wu, Jingjing Qu, Jing Zheng, et al.
Immunotherapy|November 18, 2024
ctDNA-guided adjuvant immunotherapy in colorectal cancerNicholas Burley, Yurhee Lee, Louisa Liu, et al.
Immunotherapy|November 16, 2024
Fatal rhabdomyolysis and fulminant myocarditis with malignant arrhythmias after one dose of ipilimumab and nivolumabMarko Kurnik, Petra Kolar Kus, Mihela Krepek, et al.
Immunotherapy|August 9, 2024
The role of nemolizumab in the treatment of atopic dermatitis for the adult populationStuti Prajapati, Joseph P Flemming, Danyaal Khan, et al.
Immunotherapy|July 17, 2024
Tocilizumab and CytoSorb for delayed severe cytokine release syndrome after ipilimumab plus nivolumab immunotherapyMarko Kurnik, Fazarinc Peter, Podbregar Matej
Immunotherapy|July 25, 2024
Selection of allergen extract for immunotherapy in polysensitized allergic rhinitis patientsElizabeth García, Juan-Camilo Ardila, Nardey Crespo, et al.
Immunotherapy|July 25, 2024
Deterioration in multifocal motor neuropathy upon treatment of immune-related adverse events of checkpoint inhibitionVera Elisabeth Adreana Kleinveld, Julia Wanschitz, Wolfgang N Löscher, et al.
Immunotherapy|July 29, 2024
A patient empowerment program for primary immunodeficiency improves quality of life in children and adolescentsMaria Fasshauer, Gesine Schuermann, Norbert Gebert, et al.
Pageof 190